Seasonal visitation restrictions at WakeMed’s facilities will go into effect on Dec. 22 to try to limit the spread of illness ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

In adults aged 60 years and older, RSV vaccines had a pooled VE against hospitalization of 79% (95% CI, 72-85) across 3 case-control studies. Effectiveness was similar in immunocompromised adults ...

As winter sets in, it brings with it a wave of familiar respiratory illnesses. Coupled with the pollution in many major ...

NEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...

It may feel like you are surrounded by sniffles and coughs, but flu season activity is still low in many parts of the U.S.

Christmas, Kwanzaa, and other end-of-year holidays typically mean travel followed by close indoor contact with friends or loved ones — near-perfect conditions for nasty airborne viruses to spread. And ...

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...

GSK secures FDA approval for its oral gonorrhoea drug as EMA backs expanded RSV vaccine and additional respiratory treatments ...

GSK (GSK) stock is in focus as an expert panel of the European Medicines Agency ((EMA)) endorses the company's Arexvy RSV ...

Early-life viral infection programs immune cells to hijack allergy-associated maternal antibodies, driving allergy risk later ...

Last year's flu season between 2024-25 saw 542 flu-related deaths, which broke state records since record keeping began in ...